Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News SillaJen and Lee’s Pharmaceutical launch Phase 3 trial of Pexa-Vec in China for advanced liver cancer In a significant development in the fight against liver cancer, South Korean biotech company SillaJen, in partnership with… bypharmanewsdailySeptember 5, 2018